Intellipharmaceutics Reports Positive Results From A Series of Phase I Clinical Trials Of Regabatin XR
October 22, 2014 at 17:15 PM EDT
Intellipharmaceutics International Inc. (Nasdaq: IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and ...